Genodermatoses

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2025-08-05
Clinical Trial Update: A 44-week Monocentric Open Study Assessing the Efficacy and Safety of Deucravacitinib in Adults With Inflammatory Genodermatoses [Phase 2]
Phase 2 monocentric trial evaluating the efficacy and safety of deucravacitinib in adults with inflammatory genodermatoses; currently recrui…